Cargando…
CD146: a potential therapeutic target for systemic sclerosis
Autores principales: | Zhang, Lingling, Luo, Yongting, Teng, Xiao, Wu, Zhenzhen, Li, Mengtao, Xu, Dong, Wang, Qian, Wang, Fei, Feng, Jing, Zeng, Xiaofeng, Yan, Xiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251808/ https://www.ncbi.nlm.nih.gov/pubmed/29671201 http://dx.doi.org/10.1007/s13238-018-0531-x |
Ejemplares similares
-
CD146 is essential for PDGFRβ-induced pericyte recruitment
por: Chen, Jianan, et al.
Publicado: (2017) -
Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis
por: Luo, Yongting, et al.
Publicado: (2017) -
Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice
por: Zeng, Qiqun, et al.
Publicado: (2014) -
CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension
por: Luo, Yongting, et al.
Publicado: (2019) -
Publisher Correction: CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension
por: Luo, Yongting, et al.
Publicado: (2019)